Thermo Fisher to sell three analytical divisions to GE Healthcare

Thermo Fisher Scientific has agreed to sell three of its analytical technology divisions to GE Healthcare for just over $1 billion (£645 million). The move is intended to satisfy the demands of US competition regulators and speed up final approval for Thermo’s ongoing takeover of Life Technologies.

GE will take over Thermo’s cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013.

Related Content

Business roundup

28 October 2009 Business

news image

Industry news, November 2009

Thermo Fisher to buy Life Technologies in $15.8bn deal

19 April 2013 Business

news image

Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets

Most Commented

How do we solve a problem like Marie?

21 May 2015 The Crucible

news image

Women in science’s history deserve better treatment than myths and martyrdom, says Philip Ball

Chemistry at heart of VW emissions cheating

28 September 2015 News and Analysis

news image

Car firm dodged nitrogen oxide pollution limits using software that detected testing